Tenaya Therapeutics (TNYA) Receivables (2026)
Tenaya Therapeutics (TNYA) posted quarterly Receivables of $10.6 million for Q1 2026.
Tenaya Therapeutics (TNYA) Receivables (2026) Analysis & Trends
Tenaya Therapeutics' Receivables history runs 1 years deep, the most recent figure standing at $10.6 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 371,000.00 |
| Mar 31, 2026 | 10.63 Mn |